MEDICAL UPDATES
VOL. 1 Series No.
MU003-2011
A Randomized Placebo Controlled Trial On The
Effect Of Arthrospira platensis
(Cellife
Powder) On The Anthropometric Parameters Of Mild
To Moderately Wasted Infants
6 -24
Months Old
Rowena A. Pua,M.D., Felizardo N. Gatcheco, M.D.,
Josephine Dy, M.D Department of Pediatrics, St.
John Hospital, Calamba, Laguna, Philippines
ABSTRACT
BACKGROUND:
Undernutrition is still a big problem among
Filipino infants and children. Nutritional
supplements may have a role in the alleviation
of this problem. The use of Arthrospira
platensis (Cellife Powder) which is rich in
protein, vitamins and minerals may be of help.
OBJECTIVE:
To determine the safety and efficacy of
Arthrospira platensis (Cellife Powder) at 1
sachet (60mg) 4 times a day for 1month versus
placebo given to infants 6 to 24 months old with
mild to moderate undernutrition.
METHODOLOGY:
After informed consent was elicited infants 6 to
24 months old with mild to moderate
undernutrition were randomized to Arthrospira
platensis (Cellife Powder) 60mg 4 times a day
for 1 month or to the placebo group.
Anthropometric parameters like weight, length
and mid-arm circumference were monitored at
baseline, on the 2nd week and at the
4th week of the trial. Caloric intake
were likewise monitored.
STATISTICAL ANALYSIS:
Descriptive statistics, independent T-test and
repeated measures were used to determine
difference in the outcomes. Level of statistical
significance was pegged at 0.05. Adverse events
were reported as proportions.
RESULTS:
48 subjects were randomized to the Arthrospira
platensis (Cellife Spirulina) Group while 51
were randomized to the placebo group. There were
no significant differences in the baseline
parameters between the 2 groups. After 2 weeks
the Arthrospira platensis (Cellife Powder) group
had a 950 g increase in their weight while only
280 g in the placebo group (p 0.0001). After 4
weeks the Arthrospira platensis (Cellife Powder)
group had a 1.5 kg increase vs 670 g increase in
the placebo group (p.0001). With regard the
length, after 2 weeks there was a 1.49 cm
increase in the Arthrospira platensis (Cellife
Powder) group vs 0.62 cm increase in the placebo
group (p 0.001). After 4 weeks the increase was
2.72 cm in the Arthrospira platensis (Cellife
Powder) groups vs 1.29 cm in the placebo group
(p 0.0001). With regard the MAC, on the 2nd
week the increase in the Arthrospira platensis (Cellife
Powder) group was 1.22mm vs 0.36 mm in the
placebo group (p 0.0001). On the 4th
week, the increase was 2.22mm in the Arthrospira
platensis (Cellife Powder) group while 0.90 mm
in the placebo group (p 0.0001). There was a 150
kcal increase in the caloric intake after 2
weeks in the Arthrospira platensis (Cellife
Powder) group vs 25 kcal in the placebo group (p
0.0001). After 4 weeks, there was a 830 kcal
increase in Arthrospira Platensis (Celilife
Powder) group vs 60 kcal increase in the placebo
group (p 0.0001). No adverse events were noted
in either group during the trial.
CONCLUSION:
There was significant improvement in the weight,
length, MAC and caloric intake of infants given
Arthrospira platensis
(Cellife Powder) vs those who received
placebo. No adverse events were noted in either
group. |
||||||||||||||||||||
.
|
||||||||||||||||||||